Main Uses of Frazole

Frazole is a medication primarily indicated for the treatment of various infections caused by susceptible anaerobic bacteria and certain protozoa. It is commonly utilized in clinical settings to address conditions affecting different parts of the body, including the abdomen, skin, and reproductive system.

Bacterial Infections

The medication is effective against a range of anaerobic bacterial infections. These may include:

• Intra-abdominal Infections: Treatment of peritonitis, liver abscesses, and infections following abdominal surgery.
• Skin and Soft Tissue Infections: Management of deep-seated skin infections caused by anaerobic organisms.
• Gynecological Infections: Addressing pelvic inflammatory disease, endometritis, and tubo-ovarian abscesses.
• Bone and Joint Infections: Used as part of a treatment regimen for osteomyelitis caused by susceptible pathogens.
• Respiratory Infections: Treatment of lower respiratory tract infections, such as aspiration pneumonia or lung abscesses.

Protozoal Infections

Frazole is also used to treat specific parasitic infections. These include:

• Amoebiasis: Management of intestinal and extra-intestinal infections caused by Entamoeba histolytica.
• Giardiasis: Treatment of infections in the small intestine caused by the Giardia parasite.
• Trichomoniasis: Addressing infections of the genitourinary tract in both men and women.

Benefits and Clinical Goals

The primary benefit of Frazole is its targeted action against anaerobic organisms that are often resistant to other types of antibiotics. By inhibiting the DNA synthesis of these specific pathogens, the medication helps to:

• Resolve Symptoms: Reduce fever, pain, and inflammation associated with active infection.
• Prevent Complications: Decrease the risk of the infection spreading to other organs or becoming systemic.
• Support Recovery: Clear the underlying pathogen to allow the body's tissues to heal, particularly after surgical procedures where anaerobic contamination is a risk.

In some instances, Frazole may be used in combination with other antimicrobial agents to provide broad-spectrum coverage when multiple types of bacteria are suspected to be present.

Official Eligibility Rules for Frazole (Omeprazole)

Frazole's use is defined by regulatory criteria outlining approved and prohibited populations. The medicine is contraindicated and must not be used by patients with a known hypersensitivity to omeprazole, related benzimidazoles, or any component of the formulation. It is also contraindicated for patients concurrently taking nelfinavir or rilpivirine-containing products.

Population Group	Regulatory Status
Adults & Older Adults	Approved for use across labeled indications.
Pediatric Patients	Approved for children 1 year of age and older and 10 kg.
Infants	Use Not Established in children younger than 1 year of age.
Hepatic Impairment	Restricted Use; caution and potential dose reduction are required.
Renal Impairment	Use Permitted; no dose adjustment is typically needed.
Pregnancy/Lactation	Conditional Use; advised only if the benefit is considered to outweigh the potential risk.

Patients with certain hereditary metabolic disorders (e.g., Lapp Lactase deficiency) are also restricted from use due to formulation excipients. Eligibility is strictly governed by these official regulatory classifications.

Frazole can interact with other medicines, potentially changing how Frazole or the other medicine works. It's crucial to inform your healthcare provider about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking.

Interactions Affecting Drug Metabolism

Frazole is metabolized in the liver, primarily by the cytochrome P450 (CYP) enzyme systems, specifically CYP2C19 and, to a lesser extent, CYP3A4. Therefore, medicines that inhibit or induce these enzymes can alter the concentration of Frazole in the body.

• CYP2C19 and CYP3A4 Inhibitors (e.g., certain antifungal medications like fluconazole) may increase Frazole blood levels, raising the risk of side effects.
• CYP2C19 and CYP3A4 Inducers (e.g., rifampin, St. John's wort) may decrease Frazole blood levels, potentially reducing its effectiveness.

Clinically Significant Drug Interactions

Concomitant Medicine Category	Potential Interaction	Management
Anticoagulants (e.g., warfarin)	Increased blood levels of the anticoagulant; elevated risk of bleeding.	Close monitoring of coagulation tests (INR) and potential dose adjustment of the anticoagulant.
CNS Depressants (e.g., diazepam)	Frazole can inhibit the metabolism of some CNS depressants, increasing their effect.	Careful monitoring for increased sedative effects; dose reduction may be necessary.

Interactions Affecting Absorption

Frazole reduces stomach acid, which can affect the absorption of other medicines that require an acidic environment for proper absorption. This may include certain antivirals or iron salts, leading to reduced effectiveness of these medicines. Conversely, the absorption of some medicines, such as digoxin, may be increased.

Irreversible Blockade of the Proton Pump

Frazole acts as an irreversible inhibitor of the H^+/ K^+-Adenosinetriphosphatase ( H^+/ K^+-ATPase) enzyme, known as the Proton Pump, located in gastric parietal cells. The drug is a prodrug that must first concentrate and be chemically activated by the highly acidic environment ( pH < 4) within the cell's secretory canaliculi. Once activated, the compound forms a permanent, covalent bond with cysteine residues on the enzyme, physically and chemically blocking the pump’s function.

---

Time-Dependent Action and Physiological Consequences

This mechanism effectively blocks the last step of acid production regardless of the stimulating signal (e.g., Histamine or Gastrin), resulting in a significant reduction in gastric acid output. Because the inhibition is permanent, acid secretion only resumes when the parietal cell synthesizes and inserts new pumps. Consequently, the maximal acid output inhibition is achieved only cumulatively after several daily doses. The sustained reduction of intragastric acidity functionally disrupts the stomach's normal hormonal feedback, leading to a compensatory change—an increase in the release of the hormone Gastrin in the bloodstream.

Frazole is typically taken once daily, usually before a meal, to reduce the production of stomach acid. The specific dosage and duration of therapy are determined by a healthcare provider based on the condition being treated, such as gastroesophageal reflux disease (GERD) or duodenal ulcers. It is essential to follow the prescribed regimen exactly as ordered, without taking more or less than directed.

Administration Guidelines

Dosage Form	Instruction
Delayed-Release Capsules/Tablets	Swallow the medication whole with a glass of water. Do not crush, chew, or split the capsule or tablet, as this can affect how the drug is absorbed.
Difficulty Swallowing	For delayed-release capsules, if you cannot swallow the capsule whole, the pellets inside can be sprinkled onto one tablespoon of applesauce. Swallow this mixture immediately with a glass of cool water without chewing the pellets. Do not prepare the mixture in advance.
Timing	The dose is generally taken 30 to 60 minutes before the first meal of the day, as directed by your physician. For some regimens, particularly those involving H. pylori eradication, a second daily dose may be required before the evening meal.

If a dose is missed, take it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at once to compensate for a missed dose.

Evidence for the Healing and Maintenance of Erosive Esophagitis

This section summarizes the structure of clinical trials, primarily Randomized Controlled Trials (RCTs), that have evaluated the use of Frazole for exploring the healing of damaged esophageal tissue and observing that healing over time. It will describe the outcomes studied, such as endoscopic measurements and symptom relief assessments.

Studies was evaluated in short-term RCTs, typically lasting 4 to 8 weeks, which used in research exploring the physical healing of the esophagus in adults with injury caused by acid reflux. These trials aimed to measure the proportion of patients who achieved complete tissue healing, often confirmed by endoscopy. Researchers also applied in studies examining how symptoms evolved during this period, focusing on key outcomes related to patient-reported outcomes describing perceived discomfort from heartburn and acid regurgitation.

Findings from research suggest that when Frazole was evaluated in trials exploring healing Erosive Esophagitis, observed patterns included measurements of mucosal repair when compared to studies using a placebo or H2-receptor antagonists. In addition, trials lasting 6 to 12 months were conducted to observe whether the healing of the esophageal tissue was maintained over the follow-up period. These maintenance studies report how symptoms evolved in the observed populations, helping to understand patterns related to the observed changes in the short term and whether these continued over longer intervals.

Long-term outcomes are not well characterized beyond one year regarding continuous healing. While patterns were established in early trials, the data for certain groups remain insufficient, especially for understanding long-term use and its specific impact on tissue health.

---

️ Evidence for Symptom Management in Reflux Disease and Ulcer Healing

This section covers the research landscape for two primary areas: trials examining Frazole’s use for the symptom cluster of frequent heartburn in reflux disease without erosions, and studies assessing its role in the short-term healing of gastric and duodenal ulcers. It outlines the types of research designs used, including placebo-controlled trials and combination therapy studies.

For patients experiencing frequent reflux symptoms but without visible damage to the esophagus, Frazole was evaluated in short-term placebo-controlled RCTs. Research examined outcomes related to patient-reported experiences, specifically measuring the number of days patients reported complete resolution of heartburn and changes in their overall daily functioning or activity level.

Findings describe patterns observed in the studies where research explored a reported change in symptom intensity over a few weeks, which contributes to the broader evidence landscape for managing conditions where symptoms may vary in intensity. The evidence highlights what is known—and what is still uncertain—about managing these short-term, episodic symptoms.

Key Studies & References

1. Longterm maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study
2. Omeprazole: a review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs

Common questions about Frazole (FAQ)

Q: What is the main reason Frazole is typically prescribed?

A: Frazole is a medicine prescribed to reduce the production of stomach acid. Official documents state that it is used to treat conditions such as Gastroesophageal Reflux Disease (GERD), to help heal duodenal ulcers and gastric ulcers, and to treat injury to the esophagus caused by acid (known as Erosive Esophagitis).

Q: Is Frazole the same kind of medicine as other common treatments for this condition?

A: Frazole belongs to a class of medicines called Proton Pump Inhibitors (PPIs). This means it works by directly blocking the final step of acid production inside the stomach cells. This mechanism is different from that of antacids, which neutralize acid, or H2 blockers, which reduce histamine signals.

Q: Is Frazole considered a long-term or short-term treatment?

A: Frazole is primarily intended for short-term treatment, typically lasting 4 to 8 weeks for many prescription conditions. Over-the-counter products are typically labeled for a 14-day course. Long-term use is associated with specific risks, and regulatory documents suggest monitoring may be necessary.

Q: What are the most common side effects reported with Frazole?

A: According to official product information, the most common side effects reported during clinical trials were typically mild. These generally include headache, stomach pain, nausea, diarrhea, vomiting, and gas.

Q: How long do the side effects of Frazole usually last?

A: Common side effects are often temporary as the body adjusts to the medication. Regulatory information suggests these effects may resolve within a few days to a couple of weeks as the body adjusts to the medication.

Q: Can Frazole cause stomach or digestive issues?

A: Yes, regulatory information indicates that Frazole can cause various common gastrointestinal side effects. These include stomach pain, diarrhea, nausea, vomiting, and flatulence (gas).

Q: Is it common to feel unusually tired when starting Frazole?

A: Tiredness, also described as asthenia or fatigue, has been reported as a side effect in studies and post-marketing surveillance. This is categorized as a common or uncommon occurrence.

Q: Are there any serious side effects associated with Frazole use described in official documents?

A: Official warnings describe several potential serious issues, particularly with long-term or high-dose use. These include an increased risk of bone fractures, severe skin reactions, kidney problems, and a risk of Clostridium difficile-associated diarrhea.

Q: Can I drink alcohol while taking Frazole?

A: Alcohol does not directly interact with how Frazole works in the body. However, official information notes that consuming alcohol can often worsen the symptoms of acid reflux, which may counteract the medication's therapeutic effect.

Q: Does Frazole interact with common over-the-counter pain relievers?

A: Regulatory documents describe a general caution regarding the concomitant use of NSAIDs (nonsteroidal anti-inflammatory drugs, such as ibuprofen). Regulatory documents caution that the combined use of these medicines is associated with an increased risk of stomach bleeding.

Q: What are the potential interactions between Frazole and herbal supplements?

A: Official labeling indicates that co-administration of Frazole with the herbal supplement St. John's wort is not recommended. This is because St. John's wort can decrease the blood levels of Frazole, potentially reducing its effectiveness in controlling stomach acid.

Q: Is it generally safe to take Frazole with a daily multivitamin?

A: Frazole reduces stomach acid, which can affect how certain nutrients and other medications are absorbed. This includes iron salts often found in multivitamins. Furthermore, long-term use (over 3 years) is associated with warnings regarding Vitamin B-12 deficiency.

Q: How long does it typically take for Frazole to start having an effect?

A: The medication begins to reduce acid production within one hour, and some people may notice initial relief within 24 hours. However, the full, maximum acid-blocking effect is typically achieved after 1 to 4 days of taking the medicine consistently.

Q: How long is the typical course of Frazole treatment?

A: For prescription conditions like GERD or ulcers, the typical treatment course is 4 to 8 weeks. For over-the-counter use, the duration is limited to a 14-day course of treatment.

Q: Can Frazole be stopped suddenly according to official information?

A: When Frazole is discontinued, the process of acid secretion returning to pre-treatment levels occurs gradually over a period of about 3 to 5 days. Decisions about discontinuing the medication are the responsibility of the prescribing healthcare provider.

Q: Does Frazole require regular medical checkups or tests?

A: For individuals taking Frazole for an extended period, the official labeling notes that a healthcare provider may check the level of magnesium in the blood. This monitoring is done due to the potential risk of developing low magnesium levels (hypomagnesemia) associated with long-term use.

Q: Can children take Frazole?

A: Yes, regulatory agencies have approved Frazole for use in pediatric patients aged 1 year and older for certain acid-related conditions, such as GERD and Erosive Esophagitis. The appropriate dosage depends on the child's weight and condition.

Q: Is Frazole generally safe to use during pregnancy or while breastfeeding?

A: Available information indicates that use during pregnancy does not suggest an increased chance of birth defects. The medicine is found in breast milk at low levels. Decisions regarding its use during pregnancy or breastfeeding are made by a healthcare provider.

Q: Is there a specific warning about Frazole use for older adults?

A: Official warnings indicate that older adults have a higher risk for bone fractures when taking Frazole, particularly when used long-term or at higher doses. This risk factor is noted in the official warnings.

Q: Does Frazole carry a warning for people with liver or kidney conditions?

A: The drug's metabolism can be affected in people with liver problems. Furthermore, the label describes a risk of developing kidney problems, such as acute tubulointerstitial nephritis, at any time during treatment.

Q: Does Frazole affect a person's ability to drive or operate machinery?

A: Reported side effects of Frazole include dizziness and drowsiness (somnolence). Official information notes that these side effects have the potential to impair attention, which may affect activities like driving or operating machinery.

Q: Where can I find the official prescribing information or patient leaflet for Frazole?

A: Official labeling information and patient-friendly documents are published by government regulatory bodies. These can be accessed through public databases such as the FDA DailyMed database under the drug's active ingredient name.

Q: Has Frazole been approved by major regulatory bodies like the FDA or EMA?

A: Yes, the medication has been approved and registered by major regulatory bodies such as the U.S. Food and Drug Administration (FDA) for the treatment of its approved indications.

Q: Can Frazole affect the results of any common lab tests?

A: Frazole may interfere with the results of diagnostic tests for Neuroendocrine Tumors. Additionally, for patients on certain blood thinners or on long-term therapy, monitoring of coagulation tests (INR) and magnesium levels may be required.

Q: What should be done in the event of an overdose of Frazole?

A: Regulatory information advises seeking emergency medical attention or contacting a poison control center in the event of a suspected overdose.

Q: Can Frazole cause headaches, and how common is this?

A: Headache is listed in the official documents as one of the most common adverse reactions reported by adults during clinical trials and post-marketing experience.

Q: How is Frazole stored, according to the manufacturer?

A: Official product information advises that Frazole should be stored at room temperature, typically 20 C to 25 C (68 F to 77 F). It must be kept in the provided packaging to be protected from moisture.

Q: Is Frazole a generic or a brand-name medication?

A: Frazole (Omeprazole) is available in both generic and brand-name forms. It is sold as both a prescription-strength product and an over-the-counter option, depending on the dosage and indication.

Q: Can I use Frazole if I have a history of heart problems?

A: The label contains warnings about the symptoms of heartburn mimicking a heart attack, and cautions against the potential for abnormal heart rhythm due to low magnesium levels (hypomagnesemia). These potential risks are matters to be discussed with the prescribing healthcare provider.

Q: Is Frazole known to cause any long-term health issues?

A: Long-term use is associated with warnings for several potential issues, including bone fractures, low magnesium levels, Vitamin B-12 deficiency (with use over three years), and increased risk of certain gastrointestinal infections.

Q: Does Frazole contain any common allergens, like lactose or gluten?

A: Official labeling includes a list of inactive ingredients. Frazole capsules/tablets may contain ingredients such as lactose. The complete list of inactive ingredients should be consulted if there are known allergies.

Q: How quickly does Frazole leave the body?

A: The medication is eliminated from the plasma relatively quickly, with a short plasma half-life of approximately 0.5 to 1 hour in healthy subjects. However, the acid-blocking effect lasts much longer because of its irreversible mechanism of action.

The storage and disposal of Frazole (Omeprazole) are strictly defined by official regulatory labeling to ensure product integrity.

Storage Requirements

Frazole must be stored at a temperature not exceeding 25 C and requires protection from light and moisture. For blister packs, the medicine must remain in its original package. For HDPE bottles, the container must be kept tightly closed; once opened, the in-use shelf-life is 100 days. The medicine must always be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired Frazole product must be disposed of in accordance with local requirements. Health authorities advise against disposal via wastewater. If drug take-back programs are unavailable, the FDA recommends mixing the medicine with an undesirable substance (such as dirt) before sealing it in a container for disposal in the household trash.